Related Experiment Videos
[Multimodal evoked potentials in human immunodeficiency virus infection].
H Somma-Mauvais1, H Régis, J L Gastaut
1Service d'Explorations Fonctionnelles du Système Nerveux, Hôpital de La Timone, Marseille.
Revue Neurologique
|January 1, 1990
Summary
Multimodal evoked potentials (MEP) are highly sensitive for detecting neurological damage in HIV patients, even those without symptoms. Abnormal MEP results increase with HIV progression and are frequent in symptomatic individuals.
Area of Science:
- Neuroscience
- Infectious Diseases
- Electrophysiology
Context:
- Human Immunodeficiency Virus (HIV) infection can lead to neurological complications.
- Early detection of neurological involvement is crucial for patient management.
- Multimodal evoked potentials (MEP) offer a non-invasive method to assess neurological function.
Purpose:
- To evaluate the sensitivity of multimodal evoked potentials (MEP) in detecting subclinical and clinical neurological abnormalities in HIV-seropositive patients.
- To compare the diagnostic utility of MEP with other electrophysiological (EEG, EMG) and neuroimaging (CT, MRI) techniques.
Summary:
- A study of 95 HIV patients found abnormal MEP in 54.7% of cases, with higher prevalence in symptomatic patients (85.7%) and increasing frequency with HIV progression.
- MEP abnormalities were observed across all modalities (visual, brainstem auditory, somatosensory) and were sensitive even in asymptomatic individuals.
- Compared to EEG and neuroimaging, MEP demonstrated higher sensitivity for detecting neurological changes at all stages of HIV infection, with EMG serving as a complementary method.
Impact:
- Multimodal evoked potentials (MEP) are a valuable and sensitive tool for early diagnosis and monitoring of neurological complications in HIV infection.
- Findings highlight the utility of MEP in identifying subclinical neurological damage, guiding timely intervention.
- This study underscores the importance of electrophysiological assessments in the comprehensive management of HIV-associated neurological disorders.